Conversion from mycophenolate mofetil to azathioprine in high-risk renal allograft recipients on cyclosporine-based immunosuppression
10.1016/j.transproceed.2004.08.104
Saved in:
Main Authors: | Lou, HX, Vathsala, A |
---|---|
Other Authors: | MEDICINE |
Format: | Conference or Workshop Item |
Published: |
Elsevier BV
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/229717 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Proteinuria in cyclosporine-treated renal transplant recipients.
by: Vathsala, A, et al.
Published: (2022) -
Outcome of renal transplantation under cyclosporine immunosuppression in patients with lupus nephritis
by: Cobankiat, J, et al.
Published: (2022) -
Safety and efficacy of mycophenolate mofetil for prophylaxis in Asian renal transplant recipients
by: Suhail, SM, et al.
Published: (2022) -
Is a standard fixed dose of mycophenolate mofetil ideal for all patients?
by: Yau, Wai-Ping, et al.
Published: (2022) -
Abbreviated cyclosporine pharmacokinetic profiling in clinical renal transplantation: From principles to practice
by: Vathsala, A, et al.
Published: (2022)